+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Advanced Visualization Market - Growth, Trends, and Forecast (2020 - 2025)

  • PDF Icon


  • 110 Pages
  • February 2020
  • Region: Global
  • Mordor Intelligence
  • ID: 4987364
The advanced visualization market is expected to register a CAGR of 11.3% over the forecast period. The major factors for the growth of the market include the increasing prevalence of chronic diseases coupled with growing geriatric population, and rising awareness of benefits associated with advanced visualization tools in disease diagnosis.

According to the United States Census Bureau’s Statistics as of 2017, the total number of people aged 65 and older had exceeded 50 million, and between 2020-2030 the number of elderly people is projected to increase by almost 18 million. Although much smaller in total size, the number of people aged 85 and older is expected to be more than triple from an estimated 6 million currently to nearly 20 million by 2060. The rise in geriatric population will increase the patient pool suffering from various chronic diseases and advanced visualization tools are expected to increase the correct diagnosis rate among the patients. Hence, the market is expected to witness high growth.

Key Market Trends

Oncology Segment by Clinical Application is Expected to Witness High Growth over the Forecast Period

The major factors driving growth of the market includes rising technological advancements and increase in the adoption of the advanced visualization tools in healthcare facilitites. Furhermore, the rising prevalence of various types of cancer is expected to boost the demand for advanced visualization systems over the forecast period. The global cancer burden is increasing, and thus, cancer therapies must be modified according to regional and national priorities. According to the World Cancer Research Fund, in 2018, there were an estimated 18 million cancer cases around the world, out of which, 9.5 million cases were in men and 8.5 million in women.

Also, major market players are launching new products in the market. For instance, in Febrauary 2019, Philips announced the launch of IntelliSpace Portal 11, which is an advanced visualization and quantification software.

Thus, considering all the above mentioned factors the market is expected to witness high CAGR over the forecast period.

North America is Expected to hold a Significant Market Share over the Forecast Period

North America expected to hold a major market share in the global advanced visualization market due to increasing cases of chronic diseases and presence of better healthcare infrastructure. Information systems have tremendous potential in reducing healthcare costs and improving outcomes. These systems play a major role, not only in reducing costs but also in improving the accurate diagnosis. In the United States most of the hospitals are focusing on providing the value-based care. The advanced visualization systems are expected to help healthcare providers to do the same. Hence, the market is expected to witness high growth over the forecast period.

Competitive Landscape

The advanced visualization market is moderately consolidated market. Some of the market players in advanced visualization market are AGFA-Gevaert N.V., Canon Medical Systems, Carestream Health, Inc., Fujifilm Holdings Corporation, GE Healthcare, Koninklijke Philips N.V., PRO Medicus Limited, Siemens Healthineers, and Terarecon, Inc.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format.
  • Report customization as per the client's requirements.
  • 3 months of analyst support.

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Assumptions
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Chronic Diseases Coupled With Growing Geriatric Population
4.2.2 Rising Awareness of Benefits associated with Advanced Visualization Tools in Disease Diagnosis
4.3 Market Restraints
4.3.1 Limited Availability of Reimbursements for Radiology-Based Diagnostic Procedures
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Product & Service
5.1.1 Hardware
5.1.2 Software
5.1.3 Services
5.2 By Type of Solution
5.2.1 Enterprise
5.2.2 Standalone
5.3 By Imaging Modality
5.3.1 Magnetic Resonance Imaging (MRI)
5.3.2 Computed Tomography (CT)
5.3.3 Ultrasound
5.3.4 Nuclear Medicine
5.3.5 Other
5.4 By Clinical Application
5.4.1 Oncology
5.4.2 Orthopedics
5.4.3 Cardiovascular
5.4.4 Neurology
5.4.5 Others
5.5 Geography
5.5.1 North America United States Canada Mexico
5.5.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.5.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.5.4 Middle-East and Africa GCC South Africa Rest of Middle East and Africa
5.5.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 AGFA-Gevaert N.V.
6.1.2 Canon Medical Systems
6.1.3 Carestream Health, Inc.
6.1.4 Fujifilm Holdings Corporation
6.1.5 GE Healthcare
6.1.6 Koninklijke Philips N.V.
6.1.7 PRO Medicus Limited
6.1.8 Siemens Healthineers
6.1.9 Terarecon, Inc.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AGFA-Gevaert N.V.
  • Canon Medical Systems
  • Carestream Health, Inc.
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Koninklijke Philips N.V.
  • PRO Medicus Limited
  • Siemens Healthineers
  • Terarecon, Inc.